Updates from ASCO 2022 - Metastatic Breast Cancer Trial Talk

Conference Talk

The American Society of Clinical Oncology (ASCO) held its annual meeting from June 3-7, 2022. Visit the links below for research highlights from the meeting, including survey results about Black people’s attitudes about clinical trial participation.

ASCO 2022
Trastuzumab Deruxtecan (Enhertu®) for HER2-Low MBC
Sacituzumab Govitecan (Trodelvy®) for Hormone Receptor-Positive MBC
BECOME (Black Experience of Clinical Trials and Opportunities for Meaningful Engagement) Survey Results



for past articles or specific information.